New York psilocybin news
What changed, when, and the primary record behind it: bills in Albany, enforcement in the five boroughs, research at New York hospitals and the neighbors' new laws.
From our sister shop, My Mushroom Dispensary. Adults 21+ only.
Every post links to the bill page, court filing, agency release, registry entry or journal article it reports on. Corrections are made in the open, as our editorial standards describe. For the running record, see the Albany bill tracker and the New York trials list. New posts also go out by RSS.
- Albany bill for a $5 million veterans psilocybin pilot is rewritten
A3845A and S1801A add $5 million, SUNY partners and statewide eligibility for veterans and first responders.
- State Police and cannabis regulators shut a Rome, NY boutique accused of selling psilocybin mushrooms
Police say a Rome new age shop fronted for psilocybin and cannabis sales. Owners face felonies; OCM padlocked it.
- NYU's psilocybin trial for people on methadone opens at Brooklyn and Bronx treatment programs
A federally funded NYU trial tests one psilocybin session for people on methadone who still use opioids.
- Most abstinent NYU trial patients stayed in remission after an extra psilocybin session, but heavy drinkers' gains faded
NYU follow-up of 59 adults with alcohol use disorder: no serious adverse events; heavy drinkers' cuts were short-lived.
- New York bill would follow federal rescheduling of psychedelic medicines automatically
S9852 and A11499 would skip the state regulation step after the FDA approves and the DEA reschedules a medicine.
- New Jersey funds a $6 million psilocybin pilot at three hospitals
P.L.2025, c.296 gives three hospitals $2 million each for psilocybin research. It doesn't legalize psilocybin.
- Mount Sinai opens an MDMA trial for bulimia as NYU adds a psilocybin study for lingering anhedonia
New Manhattan studies: MDMA-assisted therapy for bulimia at Mount Sinai, psilocybin for anhedonia at NYU Langone.
- Albany sponsors narrow New York's psilocybin bill to a medical program
A2142A and S5303A swap a broad permit plan for a Health Department medical program that would start July 1, 2028.
- Connecticut opens its psychedelic therapy pilot to more adults
Public Act 26-108 opens the MDMA and psilocybin therapy pilot to adults 18 and older who meet clinical criteria.
- Compass Pathways' psilocybin drug is in priority FDA review, and New York sites helped test it
COMP360 has rolling FDA review and a priority voucher. NY sites helped test it; state drug schedules must change too.
- Bronx VA starts a psilocybin safety trial for depression after spinal cord injury
The Bronx VA is testing psilocybin's safety in a planned 30 people with spinal cord injury and depression.
- Task force seizes about 30 pounds of psilocybin mushrooms in the Bronx
A DEA-led team with the NYPD and State Police searched a home near Yankee Stadium; two men face state felony charges.